About this Journal Submit a Manuscript Table of Contents
BioMed Research International
Volume 2013 (2013), Article ID 298401, 6 pages
http://dx.doi.org/10.1155/2013/298401
Research Article

Leptin Increases Blood Pressure and Markers of Endothelial Activation during Pregnancy in Rats

Faculty of Medicine, Universiti Teknologi MARA, 47100 Sg Buloh, Selangor, Malaysia

Received 10 April 2013; Revised 13 August 2013; Accepted 23 August 2013

Academic Editor: Rei Shibata

Copyright © 2013 Hisham Saleh Ibrahim et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. J. Scarpace and M. Matheny, “Leptin induction of UCP1 gene expression is dependent on sympathetic innervation,” American Journal of Physiology—Endocrinology and Metabolism, vol. 275, no. 2, pp. E259–E264, 1998. View at Scopus
  2. J. E. Schneider, R. M. Blum, and G. N. Wade, “Metabolic control of food intake and estrous cycles in Syrian hamsters. I. Plasma insulin and leptin,” American Journal of Physiology—Regulatory Integrative and Comparative Physiology, vol. 278, no. 2, pp. R476–R485, 2000. View at Scopus
  3. M. Abelenda, A. Ledesma, E. Rial, and M. Puerta, “Leptin administration to cold-acclimated rats reduces both food intake and brown adipose tissue thermogenesis,” Journal of Thermal Biology, vol. 28, no. 6-7, pp. 525–530, 2003. View at Publisher · View at Google Scholar · View at Scopus
  4. M. A. Pelleymounter, M. J. Cullen, M. B. Baker et al., “Effects of the obese gene product on body weight regulation in ob/ob mice,” Science, vol. 269, no. 5223, pp. 540–543, 1995. View at Scopus
  5. P. J. Scarpace, M. Matheny, B. H. Pollock, and N. Tümer, “Leptin increases uncoupling protein expression and energy expenditure,” American Journal of Physiology—Endocrinology and Metabolism, vol. 273, no. 1, pp. E226–E230, 1997. View at Scopus
  6. S. Collins, C. M. Kuhn, A. E. Petro, A. G. Swick, B. A. Chrunyk, and R. S. Surwit, “Role of leptin in fat regulation,” Nature, vol. 380, no. 6576, p. 677, 1996. View at Publisher · View at Google Scholar · View at Scopus
  7. K. Rahmouni and W. G. Haynes, “Leptin and the cardiovascular system,” Recent Progress in Hormone Research, vol. 59, no. 1, pp. 225–244, 2004. View at Publisher · View at Google Scholar · View at Scopus
  8. M. P. Nasrallah and F. N. Ziyadeh, “Overview of the physiology and pathophysiology of leptin with special emphasis on its role in the kidney,” in Seminars in Nephrology, Elsevier, 2013.
  9. F. Schinzari, M. Tesauro, V. Rovella et al., “Leptin stimulates both endothelin-1 and nitric oxide activity in lean subjects but not in patients with obesity-related metabolic syndrome,” Journal of Clinical Endocrinology & Metabolism, vol. 98, no. 3, pp. 1235–1241, 2013. View at Publisher · View at Google Scholar
  10. M. Aizawa-Abe, Y. Ogawa, H. Masuzaki et al., “Pathophysiological role of leptin in obesity-related hypertension,” Journal of Clinical Investigation, vol. 105, no. 9, pp. 1243–1252, 2000. View at Scopus
  11. A. S. Greenberg and M. S. Obin, “Obesity and the role of adipose tissue in inflammation and metabolism,” American Journal of Clinical Nutrition, vol. 83, no. 2, pp. 461S–465S, 2006. View at Scopus
  12. S. Mehta and J. A. Farmer, “Obesity and inflammation: a new look at an old problem,” Current Atherosclerosis Reports, vol. 9, no. 2, pp. 134–138, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. M. Wolf, E. Kettyle, L. Sandler, J. L. Ecker, J. Roberts, and R. Thadhani, “Obesity and preeclampsia: the potential role of inflammation,” Obstetrics and Gynecology, vol. 98, no. 5, pp. 757–762, 2001. View at Publisher · View at Google Scholar · View at Scopus
  14. J. C. Madan, J. M. Davis, W. Y. Craig et al., “Maternal obesity and markers of inflammation in pregnancy,” Cytokine, vol. 47, no. 1, pp. 61–64, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. F. M. H. Van Dielen, C. Van't Veer, A. M. Schols, P. B. Soeters, W. A. Buurman, and J. W. M. Greve, “Increased leptin concentrations correlate with increased concentrations of inflammatory markers in morbidly obese individuals,” International Journal of Obesity, vol. 25, no. 12, pp. 1759–1766, 2001. View at Publisher · View at Google Scholar · View at Scopus
  16. K. Miehle, H. Stepan, and M. Fasshauer, “Leptin, adiponectin and other adipokines in gestational diabetes mellitus and pre-eclampsia,” Clinical Endocrinology, vol. 76, no. 1, pp. 2–11, 2012. View at Publisher · View at Google Scholar · View at Scopus
  17. H. J. Singh, A. A. Bakar, A. C. Romli, and A. Nila, “Raised leptin concentrations in feto-placental tissues from women with preeclampsia,” Hypertension in Pregnancy, vol. 24, no. 2, pp. 191–199, 2005. View at Publisher · View at Google Scholar · View at Scopus
  18. J. C. Chambers, L. Fusi, I. S. Malik, D. O. Haskard, M. De Swiet, and J. S. Kooner, “Association of maternal endothelial dysfunction with preeclampsia,” Journal of the American Medical Association, vol. 285, no. 12, pp. 1607–1612, 2001. View at Scopus
  19. J. M. Roberts and K. Y. Lain, “Recent insights into the pathogenesis of pre-eclampsia,” Placenta, vol. 23, no. 5, pp. 359–372, 2002. View at Publisher · View at Google Scholar · View at Scopus
  20. M. N. Haron, U. J. A. D'Souza, H. Jaafar, R. Zakaria, and H. J. Singh, “Exogenous leptin administration decreases sperm count and increases the fraction of abnormal sperm in adult rats,” Fertility and Sterility, vol. 93, no. 1, pp. 322–324, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. J. Bella, P. R. Kolatkar, C. W. Marlor, J. M. Greve, and M. G. Rossmann, “The structure of the two amino-terminal domains of human ICAM-1 suggests how it functions as a rhinovirus receptor and as an LFA-1 integrin ligand,” Proceedings of the National Academy of Sciences of the United States of America, vol. 95, no. 8, pp. 4140–4145, 1998. View at Publisher · View at Google Scholar · View at Scopus
  22. Z. Vadasz, T. Haj, K. Halasz et al., “Semaphorin 3A is a marker for disease activity and a potential immunoregulator in systemic lupus erythematosus,” Arthritis Research & Therapy, vol. 14, no. 3, article R146, 2012. View at Publisher · View at Google Scholar
  23. A. N. Faria, F. F. Ribeiro Filho, S. R. G. Ferreira, and M. T. Zanella, “Impact of visceral fat on blood pressure and insulin sensitivity in hypertensive obese women,” Obesity Research, vol. 10, no. 12, pp. 1203–1206, 2002. View at Scopus
  24. W. G. Haynes, D. A. Morgan, S. A. Walsh, A. L. Mark, and W. I. Sivitz, “Receptor-mediated regional sympathetic nerve activation by leptin,” Journal of Clinical Investigation, vol. 100, no. 2, pp. 270–278, 1997. View at Scopus
  25. J. C. Dunbar, Y. Hu, and H. Lu, “Intracerebroventricular leptin increases lumbar and renal sympathetic nerve activity and blood pressure in normal rats,” Diabetes, vol. 46, no. 12, pp. 2040–2043, 1997. View at Scopus
  26. M. L. G. Correia and K. Rahmouni, “Role of leptin in the cardiovascular and endocrine complications of metabolic syndrome,” Diabetes, Obesity and Metabolism, vol. 8, no. 6, pp. 603–610, 2006. View at Publisher · View at Google Scholar · View at Scopus
  27. M. Madajka, M. Korda, J. White, and T. Malinski, “Effect of aspirin on constitutive nitric oxide synthase and the biovailability of NO,” Thrombosis Research, vol. 110, no. 5-6, pp. 317–321, 2003. View at Publisher · View at Google Scholar · View at Scopus
  28. C. A. Ecelbarger, “Proteomics and sodium transport,” Proteomics in Nephrology, vol. 141, pp. 124–141, 2004. View at Scopus
  29. R. De Caterina, L. Ghiadoni, S. Taddei et al., “Soluble E-selectin in essential hypertension: a correlate of vascular structural changes,” American Journal of Hypertension, vol. 14, no. 3, pp. 259–266, 2001. View at Publisher · View at Google Scholar · View at Scopus
  30. J. S. Yudkin, C. D. A. Stehouwer, J. J. Emeis, and S. W. Coppack, “C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue?” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 19, no. 4, pp. 972–978, 1999. View at Scopus
  31. H. O. Steinberg, H. Chaker, R. Leaming, A. Johnson, G. Brechtel, and A. D. Baron, “Obesity/insulin resistance is associated with endothelial dysfunction: implications for the syndrome of insulin resistance,” Journal of Clinical Investigation, vol. 97, no. 11, pp. 2601–2610, 1996. View at Scopus
  32. M. Hashimoto, M. Akishita, M. Eto et al., “The impairment of flow-mediated vasodilatation in obese men with visceral fat accumulation,” International Journal of Obesity, vol. 22, no. 5, pp. 477–484, 1998. View at Scopus
  33. J. J. Cha, Y. Y. Hyun, Y. H. Jee et al., “Plasma concentration of soluble intercellular adhesion molecule-1 (sICAM-1) is elevated in type 2 diabetic patients, and sICAM-1 synthesis is associated with leptin-induced activation of the mitogen-activated protein kinase (MAPK) pathway,” Inflammation, vol. 36, no. 4, pp. 878–887, 2013. View at Publisher · View at Google Scholar
  34. N. Hou and J. D. Luo, “Leptin and cardiovascular diseases,” Clinical and Experimental Pharmacology and Physiology, vol. 38, no. 12, pp. 905–913, 2011. View at Publisher · View at Google Scholar · View at Scopus
  35. J. Beltowski, “Leptin and atherosclerosis,” Atherosclerosis, vol. 189, no. 1, pp. 47–60, 2006. View at Publisher · View at Google Scholar · View at Scopus
  36. M. Y. Wang, Y. T. Zhou, C. B. Newgard, and R. H. Unger, “A novel leptin receptor isoform in rat,” FEBS Letters, vol. 392, no. 2, pp. 87–90, 1996. View at Publisher · View at Google Scholar · View at Scopus
  37. C. Serradeil-Le Gal, D. Raufaste, G. Brossard et al., “Characterization and localization of leptin receptors in the rat kidney,” FEBS Letters, vol. 404, no. 2-3, pp. 185–191, 1997. View at Publisher · View at Google Scholar · View at Scopus
  38. D. C. H. Dong Cheol Han, M. Isono, S. Chen et al., “Leptin stimulates type I collagen production in db/db mesangial cells: glucose uptake and TGF-β type II receptor expression,” Kidney International, vol. 59, no. 4, pp. 1315–1323, 2001. View at Publisher · View at Google Scholar · View at Scopus
  39. G. Wolf, A. Hamann, D. C. Han et al., “Leptin stimulates proliferation and TGF-β expression in renal glomerular endothelial cells: potential role in glomerulosclerosis,” Kidney International, vol. 56, no. 3, pp. 860–872, 1999. View at Publisher · View at Google Scholar · View at Scopus
  40. B. L. Kasiske and J. T. Crosson, “Renal disease in patients with massive obesity,” Archives of Internal Medicine, vol. 146, no. 6, pp. 1105–1109, 1986. View at Scopus
  41. K. Sharma and F. N. Ziyadeh, “The emerging role of transforming growth factor-β in kidney diseases,” American Journal of Physiology—Renal Fluid and Electrolyte Physiology, vol. 266, no. 6, pp. F829–F842, 1994. View at Scopus